Interleukin-16-producing NK cells and T-cells in the blood of tobacco smokers with and without COPD

Int J Chron Obstruct Pulmon Dis. 2016 Sep 15:11:2245-2258. doi: 10.2147/COPD.S103758. eCollection 2016.

Abstract

Background: Long-term exposure to tobacco smoke causes local inflammation in the airways that involves not only innate immune cells, including NK cells, but also adaptive immune cells such as cytotoxic (CD8+) and helper (CD4+) T-cells. We have previously demonstrated that long-term tobacco smoking increases extracellular concentration of the CD4+-recruiting cytokine interleukin (IL)-16 locally in the airways. Here, we hypothesized that tobacco smoking alters IL-16 biology at the systemic level and that this effect involves oxygen free radicals (OFR).

Methods: We quantified extracellular IL-16 protein (ELISA) and intracellular IL-16 in NK cells, T-cells, B-cells, and monocytes (flow cytometry) in blood samples from long-term tobacco smokers with and without chronic obstructive pulmonary disease (COPD) and in never-smokers. NK cells from healthy blood donors were stimulated with water-soluble tobacco smoke components (cigarette smoke extract) with or without an OFR scavenger (glutathione) in vitro and followed by quantification of IL-16 protein.

Results: The extracellular concentrations of IL-16 protein in blood did not display any substantial differences between groups. Notably, intracellular IL-16 protein was detected in all types of blood leukocytes. All long-term smokers displayed a decrease in this IL-16 among NK cells, irrespective of COPD status. Further, both NK and CD4+ T-cell concentrations displayed a negative correlation with pack-years. Moreover, cigarette smoke extract caused release of IL-16 protein from NK cells in vitro, and this was not affected by glutathione, in contrast to the decrease in intracellular IL-16, which was prevented by this drug.

Conclusion: Long-term exposure to tobacco smoke does not markedly alter extracellular concentrations of IL-16 protein in blood. However, it does decrease the intracellular IL-16 concentrations in blood NK cells, the latter effect involving OFR. Thus, long-term tobacco smoking exerts an impact at the systemic level that involves NK cells; innate immune cells that are critical for host defense against viruses and tumors - conditions that are overrepresented among smokers.

Keywords: CD4+ cells; CD69+; CD8+ cells; COPD; NK cells; interleukin-16.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Antioxidants / pharmacology
  • B-Lymphocytes / immunology
  • Case-Control Studies
  • Cell Separation / methods
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Flow Cytometry
  • Glutathione / pharmacology
  • Humans
  • Inflammation Mediators / blood*
  • Interferon-gamma / metabolism
  • Interleukin-16 / blood*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Male
  • Middle Aged
  • Monocytes / immunology
  • Oxidative Stress / drug effects
  • Pulmonary Disease, Chronic Obstructive / blood
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / etiology
  • Pulmonary Disease, Chronic Obstructive / immunology*
  • Reactive Oxygen Species / metabolism
  • Smoke / adverse effects
  • Smoking / adverse effects
  • Smoking / blood
  • Smoking / immunology*
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism
  • Time Factors

Substances

  • Antioxidants
  • IFNG protein, human
  • Inflammation Mediators
  • Interleukin-16
  • Reactive Oxygen Species
  • Smoke
  • Interferon-gamma
  • Glutathione